510(k) · Cleared
ClearedPowder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Better Care Plastic Technology Co., Ltd. · LZA Polymer Patient Examination Glove
Cleared on Jul 8, 2014 as substantially equivalent to K102096 (Syntex Healthcare Products Co., Ltd., 2010) after a 98-day review. Its family tree reaches back 2 generations to 2010.
- Decided
- Jul 8, 2014
- Review
- 98 days
- Class
- Class I
- Product code
- LZA
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K093726 (2010). No later device cites it as a predicate yet.
- Root · 2 generations backK093726 Mediguard Nitrile Examination Glove- Blue (Tested for Use with…Medline Industries, Inc. · 2010
- 1 generation backK102096 Powder Free Nitrile Examination Gloves, BlueSyntex Healthcare Products Co., Ltd. · 2010
- This deviceK140816 Powder Free Nitrile Examination Glove, Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2014
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K093726 | Mediguard Nitrile Examination Glove- Blue (Tested for Use with Chemotherapy… | Medline Industries, Inc. | 2010 | — |
| −1 | K102096 | Powder Free Nitrile Examination Gloves, Blue | Syntex Healthcare Products Co., Ltd. | 2010 | — |
| 0 (this device) | K140816 | Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs… | Better Care Plastic Technology Co., Ltd. | 2014 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZA device
- #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K102096 | Powder Free Nitrile Examination Gloves, BlueSummary page 1…I 3. Predicate Device Information: Syntex Healthcare Products Co., Ltd. Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue) (K102096) 5-1 Better Care Plastic Technology… | 2010 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 4 years and passes through 3 companies; a new generation was cleared every 3.8 years on median.
- None of the 2 ancestors has a recall.
How does its category compare?
All LZA devicesLZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · LZA
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZA
110in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZA
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZA
73in 2025
MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 21 | 95 | 0 | 7 |
| 2008 | 18 | 97 | 0 | 2 |
| 2009 | 28 | 112 | 0 | 12 |
| 2010 | 31 | 97 | 0 | 12 |
| 2011 | 26 | 122 | 0 | 9 |
| 2012 | 33 | 110 | 0 | 11 |
| 2013 | 20 | 130 | 0 | 10 |
| 2014 | 27 | 197 | 0 | 8 |
| 2015 | 20 | 112 | 1 | 12 |
| 2016 | 30 | 171 | 1 | 25 |
| 2017 | 44 | 124 | 0 | 4 |
| 2018 | 22 | 178 | 0 | 3 |
| 2019 | 25 | 212 | 0 | 21 |
| 2020 | 30 | 101 | 0 | 4 |
| 2021 | 139 | 111 | 0 | 20 |
| 2022 | 146 | 111 | 0 | 19 |
| 2023 | 62 | 92 | 0 | 24 |
| 2024 | 30 | 89 | 0 | 76 |
| 2025 | 24 | 110 | 0 | 73 |
| 2026 | 15 | 103 | 3 | — |
What is it indicated for?
A patient examination glove is disposable non-sterile device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. The tested chemotherapy drugs and their breakthrough detection times are as follows: Test Chemotherapy Drug and Concentration Average BDT Fluorouracil, 50.0mg/mi (50.OO0ppm) >240 min. Etoposide (Toposar), 20.0mg/mI (20,OO0ppm) >240 min. Cyclophosphamide (Cytoxan)…
Read the full statement (116 words)
A patient examination glove is disposable non-sterile device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
The tested chemotherapy drugs and their breakthrough detection times are as follows:
Test Chemotherapy Drug and Concentration Average BDT
Fluorouracil, 50.0mg/mi (50.OO0ppm) >240 min.
Etoposide (Toposar), 20.0mg/mI (20,OO0ppm) >240 min.
Cyclophosphamide (Cytoxan), 20mg/mi (20,OO0ppm) >240 min.
Carmustine (BCNU), 3.3mg/mi (3,300ppm) 2.3 min.
Thiotepa. 10.0mg/mil (I0,OO0ppm) 30.9 min.
Paclitaxel (Taxol), 6.0mg/mil (6,OO0ppm) >240 mmi.
Doxorubicin Hydrochloride, 2.0mg/mI (2,OO0ppm) >240 min.
Dacarbazine (DTiC), I10.0mg/mI (I10,OO0ppm) >240 min.
Cisplatin, 1.0mg/mi (l,OO0ppm) >240 min.
Please note that Carmustine and Thiotepa have extremely lowv permeation times of 2,3 minutes and 30.9 minutes, respectively.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K140816 · printed Nov 6, 2026
Cite this page
510(k) Report. “K140816: Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140816
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026